{"id":774601,"date":"2023-08-02T11:23:29","date_gmt":"2023-08-02T15:23:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/"},"modified":"2023-08-02T11:23:29","modified_gmt":"2023-08-02T15:23:29","slug":"beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/","title":{"rendered":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>BeautyHealth\u2019s SkinStylus<\/b>\u2122<b> Receives New FDA Clearance for Facial Acne Scarring<\/b><\/p>\n<p class=\"bwalignc\"><i>Now the only microneedling device FDA-cleared for use on both the face and abdomen<br \/>\n<br \/><\/i><i>Milestone achievement in just five months since BeautyHealth\u2019s acquisition of the brand<\/i><\/p>\n<p>LONG BEACH, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nThe Beauty Health Company (NASDAQ:SKIN), home to hero brand Hydrafacial, today announced the U.S. Food and Drug Administration (FDA) has cleared its SkinStylus\u2122 microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg\" alt=\"SkinStylus\u2122 (Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">SkinStylus\u2122 (Photo: Business Wire)<\/p>\n<\/div>\n<p>\nThe clearance from the FDA is a notable milestone for SkinStylus\u2122 since its acquisition by BeautyHealth in February of this year, revealing of an ambitious and accelerated path for the brand since coming under BeautyHealth\u2019s leadership.<\/p>\n<p>\n\u201cSkinStylus\u2019 new facial indication for acne scarring is a testament to BeautyHealth\u2019s innovation track record, proven brand building expertise, and our commitment to creating the future of skin health,\u201d said BeautyHealth President and Chief Executive Officer Andrew Stanleick. \u201cOur goal is to become the world\u2019s leading beauty, health and wellness platform by bringing together incredible brands and growing them into category leaders. This SkinStylus indication further unlocks the potential of the highly complementary treatments in our multi-brand ecosystem and positions SkinStylus for exponential growth in the years ahead.\u201d<\/p>\n<p>\nExpected to reach $1 billion U.S. market size by 2030<sup>1<\/sup>, microneedling is a minimally invasive treatment that is quickly becoming a favorite amongst providers and skincare lovers. Google searches for microneedling are up +20% YoY and up +88% from five years ago<sup>2<\/sup>; and the hashtag term #microneedling has over 4.4 million uses on Instagram<sup>3<\/sup>.<\/p>\n<p>\nMicroneedling uses small needles to create tiny, controlled micro injuries that help trigger collagen and elastin production, which is essential for smoother, firmer, and more even-toned skin.<\/p>\n<p>\nSkinStylus\u2122 is an esthetician-founded brand, and the SkinStylus\u2122 SteriLock\u00ae MicroSystem is designed to fit into the way medical and aesthetic professionals work, with a combined feature set they won\u2019t find anywhere else.<\/p>\n<p>\nCategorized by the FDA as a Class II Medical Device and under its new clearance, SkinStylus\u2122 SteriLock\u00ae MicroSystem is intended to be used as a microneedling treatment to improve the appearance of facial acne scars in Fitzpatrick skin types I, II, and III in patients aged 22 years and older.<\/p>\n<p>\nSkinStylus\u2122 is already FDA-cleared for the indication to improve the appearance of surgical or traumatic hypertrophic scars on the abdomen in adults aged 22 years and older. This was supported by the clinical data that was submitted to FDA during the clearance process.<\/p>\n<p>\nSkinStylus\u2122 is available at providers across the United States. Learn more by visiting SkinStylus.com.<\/p>\n<p><b>About The Beauty Health Company<\/b><\/p>\n<p>\nThe Beauty Health Company (NASDAQ: SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial\u2122 in hydradermabrasion, SkinStylus\u2122 in microneedling, and Keravive\u2122 in scalp health. Together, with our powerful community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types in more than 90 countries. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fhydrafacial.com%2Ffind-a-provider%2F&amp;esheet=53499601&amp;newsitemid=20230802207816&amp;lan=en-US&amp;anchor=https%3A%2F%2Fhydrafacial.com%2Ffind-a-provider%2F&amp;index=1&amp;md5=d048f4e504b8d4ade8f2be6e4bd3ce3d\">https:\/\/hydrafacial.com\/find-a-provider\/<\/a>, and learn more at beautyhealth.com or LinkedIn.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nCertain statements made in this release, including statements regarding the potential future market size for microneedling, are \u201cforward looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words \u201cestimates,\u201d \u201cprojected,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cforecasts,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201cbelieves,\u201d \u201cseeks,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cfuture,\u201d \u201cpropose\u201d and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.<\/p>\n<p>\nThese forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside The Beauty Health Company\u2019s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.<\/p>\n<p>\nImportant factors, among others, that may affect actual results or outcomes include The Beauty Health Company\u2019s ability to execute its business plan; market demand for SkinStylus; the ability to effectively provide complementary beauty health products and services; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; and the possibility that The Beauty Health Company may be adversely affected by other economic, business, and\/or competitive factors. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law.<\/p>\n<p>\nSources: 1. Emergen Research, Vision Research 2023. 2. Instagram Insights; data pulled as of 7\/31\/23. 3. Google Analytics data pulled as of 7\/31\/23.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230802207816r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/<\/a><\/span><\/p>\n<p>\nBeautyHealth Media: Marina Maher Communications | <a rel=\"nofollow\" href=\"mailto:HydraFacial@hellommc.com\">HydraFacial@hellommc.com<br \/>\n<\/a><br \/>BeautyHealth Investors: The One Nine Three Group | <a rel=\"nofollow\" href=\"mailto:BeautyHealthIR@the193.com\">BeautyHealthIR@the193.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Other Health General Health Specialty Consumer Medical Devices Fashion Teens Cosmetics Retail Women FDA Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1856753\/3\/HF_Logo_New.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1856754\/3\/SkinStylus.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/3\/SkinStylus_visual.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">SkinStylus\u2122 (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring Now the only microneedling device FDA-cleared for use on both the face and abdomen Milestone achievement in just five months since BeautyHealth\u2019s acquisition of the brand LONG BEACH, Calif.&#8211;(BUSINESS WIRE)&#8211; The Beauty Health Company (NASDAQ:SKIN), home to hero brand Hydrafacial, today announced the U.S. Food and Drug Administration (FDA) has cleared its SkinStylus\u2122 microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/ SkinStylus\u2122 (Photo: Business Wire) The clearance from the FDA &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-774601","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring Now the only microneedling device FDA-cleared for use on both the face and abdomen Milestone achievement in just five months since BeautyHealth\u2019s acquisition of the brand LONG BEACH, Calif.&#8211;(BUSINESS WIRE)&#8211; The Beauty Health Company (NASDAQ:SKIN), home to hero brand Hydrafacial, today announced the U.S. Food and Drug Administration (FDA) has cleared its SkinStylus\u2122 microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/ SkinStylus\u2122 (Photo: Business Wire) The clearance from the FDA &hellip; Continue reading &quot;BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-02T15:23:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring\",\"datePublished\":\"2023-08-02T15:23:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/\"},\"wordCount\":919,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230802207816\\\/en\\\/1857075\\\/4\\\/SkinStylus_visual.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/\",\"name\":\"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230802207816\\\/en\\\/1857075\\\/4\\\/SkinStylus_visual.jpg\",\"datePublished\":\"2023-08-02T15:23:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230802207816\\\/en\\\/1857075\\\/4\\\/SkinStylus_visual.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230802207816\\\/en\\\/1857075\\\/4\\\/SkinStylus_visual.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/","og_locale":"en_US","og_type":"article","og_title":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring - Market Newsdesk","og_description":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring Now the only microneedling device FDA-cleared for use on both the face and abdomen Milestone achievement in just five months since BeautyHealth\u2019s acquisition of the brand LONG BEACH, Calif.&#8211;(BUSINESS WIRE)&#8211; The Beauty Health Company (NASDAQ:SKIN), home to hero brand Hydrafacial, today announced the U.S. Food and Drug Administration (FDA) has cleared its SkinStylus\u2122 microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230802207816\/en\/ SkinStylus\u2122 (Photo: Business Wire) The clearance from the FDA &hellip; Continue reading \"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-02T15:23:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring","datePublished":"2023-08-02T15:23:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/"},"wordCount":919,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/","name":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg","datePublished":"2023-08-02T15:23:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230802207816\/en\/1857075\/4\/SkinStylus_visual.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beautyhealths-skinstylus-receives-new-fda-clearance-for-facial-acne-scarring\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BeautyHealth\u2019s SkinStylus\u2122 Receives New FDA Clearance for Facial Acne Scarring"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=774601"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/774601\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=774601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=774601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=774601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}